April 18, 2023
Holland & Knight Health Dose: April 18, 2023
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include:
- President Biden Signs Resolution Terminating the COVID-19 National Emergency
- Senators Introduce Bipartisan Insulin Bill
- Senate HELP Committee Postpones Drug Pricing Markup
- House Republicans Question FDA on the Safety of Generic Medications
- Bipartisan Effort to Address the Physician Fee Schedule
- CMS Releases FY24 IPPS Proposed Rule
- CMS Finalizes CY24 Policy Changes for Medicare Advantage and Part D – Prior Authorization Reform Included
- CMS Releases the FY24 Inpatient Rehabilitation Facility (IRF) Prospective Payment System (PPS) Proposed Rule
- HIPAA Privacy Enforcement Flexibilities
- HHS Announces National Cancer Plan to Advance Cancer Moonshot
- HHS Proposes New Rule on Transparency for Artificial Intelligence